Drinking cranberry juice could help boost the antibiotics used to treat urinary tract infections (UTIs) against drug ...
A new oral antibiotic could be a breakthrough in the fight against stubborn gonorrhoea infections, a sexually transmitted infection that health authorities warn is becoming harder to treat. In a ...
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications.
Millions of women get UTIs each year. An antibiotic 30 years in the making is finally offering hope.
Add Yahoo as a preferred source to see more of our stories on Google. Blujepa, aka gepotidacin, is the first new class of antibiotics since the 1990s. (Photo illustration: Yahoo News; photo: Getty ...
Several disease-modifying therapies for MS were associated with increased risks for urinary tract infections and urosepsis, ...
May 28 (Reuters) - Spero Therapeutics (SPRO.O), opens new tab and partner GSK (GSK.L), opens new tab are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...
In a surveillance study of over 12 million bacteria, investigators at The George Washington University and Providence Hospital found E. coli antimicrobial resistance to ciprofloxacin, the most ...
Regulators have given a new antibiotic the green light to treat urinary tract infections (UTIs) for the first time in almost three decades. Gepotidacin, also known as Blujepa, can be used by women in ...
Three lots of a drug designed to treat various urinary tract infections have been recalled because the white round tablets might have black spots from microbial contamination. The spotting of spots ...
Everyday Health on MSN
UTIs in older adults: What you need to know
UTIs occur more frequently in older adults, and particularly in older women. Learn how to spot the signs and symptoms of a ...
Between 30 and 40 percent of children with UTIs have VUR. Researchers gathered data from more than 600 pediatric patients between the ages of 2 and 71 months from 19 clinical sites across the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results